Moscow, Russia

Elena G Tischenko

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elena G Tischenko. Retrieved from https://idiyas.com/inventor/elena-g-tischenko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Elena G. Tischenko: Pioneering Urokinase Derivatives

Introduction: Elena G. Tischenko, a talented inventor based in Moscow, Russia, has made significant contributions to the field of biotechnology. With a focus on developing innovative solutions, her work encompasses the creation of urokinase derivatives that could have crucial applications in medical science.

Latest Patents: Elena holds one patent titled "Urokinase derivatives covalently bound to fibrinogen." This patent showcases her ability to innovate within the complex landscape of biomedical inventions, highlighting her work in improving therapeutic approaches.

Career Highlights: Throughout her career, Elena has demonstrated a strong dedication to research and innovation. Her expertise lies at the intersection of biochemistry and medicine, making her contributions particularly valuable for advancements in treatment methodologies.

Collaborations: Elena has collaborated with esteemed colleagues, including Alexandr V. Maximenko and Vladimir P. Torchilin. These partnerships reflect her commitment to collaboration and collective advancement within the scientific community.

Conclusion: Elena G. Tischenko stands out as a prominent inventor whose work on urokinase derivatives signifies a step forward in biotechnology. Her patent exemplifies the potential for innovation in enhancing medical treatments, potentially benefiting countless individuals in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…